[HTML][HTML] Critical success factors for high routine immunization performance: A case study of Senegal
…, AS Ellis, DM Gueye, D Mapatano, PS Mboup… - Vaccine: X, 2023 - Elsevier
Background The essential components of a vaccine delivery system are well-documented,
but robust evidence is lacking on how policies and implementation strategies are …
but robust evidence is lacking on how policies and implementation strategies are …
[HTML][HTML] Performance du GeneXpert MTB/RIF® dans le diagnostic de la tuberculose extra-pulmonaire à Dakar: 2010-2015
…, A Thiam, AN Diawara, S Mboup… - The Pan African …, 2016 - ncbi.nlm.nih.gov
… , 1 Aliou Thiam, 1 Awa Ndiaye Diawara, 1 Souleymane Mboup, 1 et Aissatou Gaye Diallo
1 … Aissatou Gaye Diallo et Souleymane Mboup ont supervisé les travaux du début à la fin. …
1 … Aissatou Gaye Diallo et Souleymane Mboup ont supervisé les travaux du début à la fin. …
[HTML][HTML] Évolution de l'implication des communautés dans la riposte à Ebola
E Mamadou Mbaye 1, S Kone 2, O Ka 3, S Mboup 1 - Santé publique, 2017 - cairn.info
Contexte : L’implication des communautés est l’une des bonnes pratiques de la lutte contre
Ebola. Elle a fait ses preuves dans d’autres contextes et fut mise en œuvre en Guinée …
Ebola. Elle a fait ses preuves dans d’autres contextes et fut mise en œuvre en Guinée …
[HTML][HTML] A Molecular Epidemiological Study of var Gene Diversity to Characterize the Reservoir of Plasmodium falciparum in Humans in Africa
Background The reservoir of Plasmodium infection in humans has traditionally been defined
by blood slide positivity. This study was designed to characterize the local reservoir of …
by blood slide positivity. This study was designed to characterize the local reservoir of …
Geographical distribution of HIV-1 group O viruses in Africa
M Peeters, A Gueye, S Mboup, F Bibollet-Ruche… - Aids, 1997 - journals.lww.com
Objective: To determine to what extent HIV-1 group O strains are present in different African
countries. Materials and methods: A total of 14 682 samples of sera from a range of patients …
countries. Materials and methods: A total of 14 682 samples of sera from a range of patients …
The Senegalese government's highly active antiretroviral therapy initiative: an 18-month follow-up study
…, I Lanièce, CT Kane, F Liégeois, L Vergne, S Mboup… - Aids, 2002 - journals.lww.com
Objective To study the feasibility, effectiveness, adherence, toxicity and viral resistance in
an African government HAART initiative. Methods A prospective observational cohort study …
an African government HAART initiative. Methods A prospective observational cohort study …
Hepatitis B viremia is associated with increased risk of hepatocellular carcinoma in chronic carriers
…, G Chen, F Shen, WY Lin, S Mboup… - Journal of medical …, 2004 - Wiley Online Library
The role of quantitative viral load in development of hepatocellular carcinoma (HCC) among
chronic hepatitis B virus (HBV) carriers was evaluated using real‐time PCR (TaqMan PCR), …
chronic hepatitis B virus (HBV) carriers was evaluated using real‐time PCR (TaqMan PCR), …
Lower human immunodeficiency virus (HIV) type 2 viral load reflects the difference in pathogenicity of HIV-1 and HIV-2
…, KU Travers, A Gueye-Ndiaye, S Mboup… - The Journal of …, 1999 - academic.oup.com
Human immunodeficiency virus type 2 (HIV-2) is less pathogenic than HIV type 1 (HIV-1),
but the mechanisms underlying this difference have not been defined. We developed an …
but the mechanisms underlying this difference have not been defined. We developed an …
Low plasma human immunodeficiency virus type 2 viral load is independent of proviral load: low virus production in vivo
Levels of virus in the plasma are closely related to the pathogenicity of human immunodeficiency
virus type 1 (HIV-1). HIV-2 is much less pathogenic than HIV-1, and infection with HIV-2 …
virus type 1 (HIV-1). HIV-2 is much less pathogenic than HIV-1, and infection with HIV-2 …
[HTML][HTML] Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in children in Africa: a randomised, observer-blind, placebo …
…, BP Ndiaye, CT Ndour, S Mboup… - The Lancet Infectious …, 2020 - thelancet.com
Background During the large 2013–16 Ebola virus outbreak caused by the Zaire Ebola virus,
about 20% of cases were reported in children. This study is the first, to our knowledge, to …
about 20% of cases were reported in children. This study is the first, to our knowledge, to …